1AI 0.00% 0.7¢ algorae pharmaceuticals limited

Passing Through the 20's, page-110

  1. 12,216 Posts.
    lightbulb Created with Sketch. 6226
    Beyond 6 months highly unlikely any placebo effect as deterioration continues... Phase I Trial Patients are at over 18 months and continue to show signs of improvement.
    Phase I, 40 capsules , single side of the brain, "Carol"....
    Phase II , Group 1 40 Both sides total 80 micro capsules, Group 2 80 Both side, 160 micro capsules, Group 3 120 Both Sides 240 micro capsules. With a greater positive response to NTCELL you diminish and reduce the Placebo Effect.
    ie 3 Trial Patients from each group have improved demonstrably above the 4th Placebo Patient.
 
watchlist Created with Sketch. Add 1AI (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.